Remgro Limited (JSE:REM)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc | Market Cap | 106.59B +32.1% |
| Revenue (ttm) | 52.25B +1.6% |
| Net Income | 4.81B -26.4% |
| EPS | 8.56 -26.3% |
| Shares Out | 553.69M |
| PE Ratio | 22.50 |
| Forward PE | 10.18 |
| Dividend | 4.21 (2.19%) |
| Ex-Dividend Date | Apr 22, 2026 |
| Volume | 711,523 |
| Average Volume | 1,353,067 |
| Open | 19,233 |
| Previous Close | 19,411 |
| Day's Range | 19,079 - 19,441 |
| 52-Week Range | 15,070 - 20,500 |
| Beta | 0.37 |
| RSI | 48.55 |
| Earnings Date | Apr 28, 2026 |
About Remgro
Remgro Limited is a principal investment firm. The firm prefers to invest in financial services, food, liquor and home care, banking, insurance, industrial, healthcare, infrastructure, information technology infrastructure services, media, and sport. It considers investments in Africa, UAE, UK, Switzerland and other international countries though investee companies. The firm typically invests in companies with significant influence and board representation. It mainly focuses on the provision of support rather than on being involved in the day-t... [Read more]
Financial Performance
In fiscal year 2025, Remgro's revenue was 51.51 billion, an increase of 2.15% compared to the previous year's 50.42 billion. Earnings were 3.30 billion, an increase of 166.16%.
Financial StatementsNews
Remgro Earnings Call Transcript: H1 2026
Headline earnings surged 38.8% year-over-year, driven by strong performances from Mediclinic, CIVH, Rainbow, and Heineken Beverages, supporting an 80% interim dividend increase. Portfolio simplification and robust cash generation position the group well amid ongoing macroeconomic and geopolitical volatility.
Remgro Ltd (FRA:RE7) Full Year 2025 Earnings Call Highlights: Strong Earnings Growth and ...
Remgro Ltd (FRA:RE7) Full Year 2025 Earnings Call Highlights: Strong Earnings Growth and Strategic Portfolio Moves
Full Year 2025 Remgro Ltd Earnings Call Transcript
Full Year 2025 Remgro Ltd Earnings Call Transcript
Remgro Earnings Call Transcript: H2 2025
Headline earnings rose 38.6% year-over-year, driven by strong performances from key portfolio companies and improved capital allocation. Dividends increased, debt was fully repaid, and portfolio simplification advanced. Positive momentum continues despite challenging market conditions.
Remgro Transcript: Investor Update
Regulatory approval is progressing, with enhanced commitments leading to Competition Commission support and an Appeals Court decision expected by September. The transaction values Maziv at ZAR 36 billion, includes significant CapEx and BEE commitments, and is expected to improve Remgro's profitability.
Remgro Transcript: CMD 2025
Strategic focus has shifted to performance optimization, disciplined capital allocation, and sustainability, with 63% of the portfolio in private assets and a strong Africa-centric approach. Growth drivers include Mediclinic’s transformation and CIVH’s fibre expansion, while portfolio simplification and improved underperforming assets should enhance returns.
Remgro Earnings Call Transcript: H1 2025
Headline earnings rose 38.7% to ZAR 3.7 billion, driven by strong operational gains in key portfolio companies and a return to profitability at Heineken Beverages. The balance sheet was de-geared, enabling a 20% dividend increase and flexibility for new investments.
Remgro Transcript: AGM 2024
The AGM covered board elections, approval of financials, and strategic updates, with all resolutions passed. Shareholders discussed executive incentives, portfolio optimization, and global risks, while management addressed diversity, ESG, and trade concerns.
Remgro’s investment in Vumatel and DFA hitting a bumpy patch
Remgro’s investment in South Africa’s telecommunications sector through Community Investment Ventures Holdings (CIVH) is hitting a bumpy patch.
Vumatel-owner now a R25.4 billion fibre giant – despite losing money
Remgro's valuation of CIVH has increased to well over R25 billion – despite the Vumatel-owner reporting a significant financial loss.
Remgro Ltd (FRA:RE7) (Q4 2024) Earnings Call Transcript Highlights: Mixed Performance Amid ...
Remgro Ltd (FRA:RE7) (Q4 2024) Earnings Call Transcript Highlights: Mixed Performance Amid Strategic Shifts
Heineken leaves a bad taste
Remgro's results for the past financial year reveal Heineken Beverages remains under significant pressure.
Remgro Earnings Call Transcript: H2 2024
Headline earnings declined 20% year-over-year due to non-recurring items and a tough macro environment, but the second half saw improved performance and a 10% increase in the annual dividend. Key investments like Mediclinic, Heineken, and CIVH faced challenges, while OUTsurance and RCL Foods delivered strong results.
Johann Rupert’s Remgro feels the pain
Remgro's profit plummeted by over 70% in its 2024 financial year due to corporate actions and poor investment performance.
Johann Rupert’s Remgro a good bet
Gary Davids, an investment analyst at Sanlam Private Wealth, says Remgro offers investors a high margin of safety with good potential upside.